We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.80 | 3.60 | 4.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.11 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/7/2024 14:12 | Really, is that your considered response. Could you possibly provide an argument to support anyone buying a single share in Eden. I doubt it. Go back to your boiler room. | ravenna23 | |
12/7/2024 14:07 | 'Might' Come on #Best~Guess surely your much more confident of Eden's demise than that? | supersonico | |
12/7/2024 14:05 | NPOVIt has been said before by people much smarter than myself.There is a sucker born every minute.The huge denial exhibited by long term holders is no longer risible, it is sad.The recent cap raise was plain wrong. Individuals buying AIM funds were putting their money into a pit. When will Eden sell anything? | ravenna23 | |
12/7/2024 13:58 | TimboI was a holder but exited when I realised this is a Board lifestyle company. Takes your money. Delivers nothing. The recent CR was a huge AIM pump designed to deprive Tim nice but dim from his capital. I am astounded that after all these years of capital loss you are accusing me of being bitter when I am one of the 1% who has made money on Eden. Obviously I have excluded the board from this statistic as they raise money from punters, then award themselves options at a 30% discount.When will you admit that you might have made a mistake? | ravenna23 | |
12/7/2024 13:49 | KITTY BISCUITS I made a 70% return on my investment in Eden. I got out when I realised that the company is no more than a lucrative pension fund for the directors. What is your current return on investment with Eden. I wager it is nothing to boast about. | ravenna23 | |
11/7/2024 20:30 | POV have you taken your medicine today? | monet | |
11/7/2024 13:43 | Ravenna, if you know the RL identity of the multi-avatar liar who infests this DB - Timbo_Slice aka Kittybiscuits recently - please DM it to me. The time for justice and restitution approacheth. The law must be facilitated. supersonico has separately notified me but I need confirmation since she is mad. Thanks | neutralpov | |
11/7/2024 10:41 | At the AGM the CFO kindly agreed the present awful treatment messed with" bee's gps" . I think he could have explained it more accurately . Bit hazy about the exact conversation - but they're onto it. | alchemy | |
11/7/2024 10:31 | I do so hope so | alchemy | |
10/7/2024 22:00 | Maybe Eden can help out here in the future.https://amp.t | wilmer100 | |
10/7/2024 14:03 | Ok so I understand his frustration and disappointment. I think the issue with this company is that it has taken a very very long time to come to anything. I say that as someone who first invested in the year 2000. Looking in the rear view mirror the reasons for that are now perfectly obvious, but equally I can see why things have changed and will continue to change for the better. It will take more time yet because of the nature of the beast but profitability really cannot be too far away now. The company managed a successful fundraise to the tune of nearly ten million pounds in difficult market conditions, only just recently, when other companies have gone bust. That says a whole lot, especially given the history | money never sleeps | |
10/7/2024 13:39 | Rav was a long-term holder and one-time believer in EDEN. Years of diminishing share prices have taken a toll. While I can't quite agree with everything he says, there are some valid points. I still hold out hope that Rav will one day rejoin EDEN. | timbo_slice | |
10/7/2024 13:22 | Have you got any reasons to support your viewpoint Ravenna. Anything at all, or just hope? Ps. Maybe the Director does not have the same wealth as you. Or maybe he has a diversified portfolio. Just a thought. | money never sleeps | |
10/7/2024 12:49 | Guess what, the new non exec director investment is less than it cost me to replace the brake rotors on my 20 year old Italian car this month. Huge. | ravenna23 | |
10/7/2024 12:42 | Ooh look, 12m free share options granted to executive directors this months. Any sales yet? THATS A BIG ZERO | ravenna23 | |
10/7/2024 12:36 | Got in early HA HA HA. This company has been burning shareholder funds for decades. SHAME. | ravenna23 | |
10/7/2024 12:34 | Cavendish are the company broker, it is their job to come up with ridiculous valuations. The last broker who raised money with AIM funds has disappeared. I wonder why? TRICKY by name TRICKY by nature. | ravenna23 | |
10/7/2024 12:31 | Pah! You have been pushing Eden for years. How much are you paid per post? One share? Must have more than the new director by now. Might be interested if the executive directors bought shares, but why should they? They get them for free. | ravenna23 | |
10/7/2024 12:28 | OK, WOW. The new director has invested 15k. Immense. He will earn that back in fees PDQ. That must have really hurt his bank balance. Keep justifying your terminal investment guys. I believe you. This is not even a good punt. AVOID. | ravenna23 | |
10/7/2024 12:02 | It is a start. He's got in early. The Company has publicly said that in their opinion, the shares today are worth north of the 20p Cavendish target. I'm sure he has done his own assessment and if he believes in 20p+ he is on to a nice little earner. | investingisatrickygame | |
10/7/2024 09:33 | It's a good start..and Nice to see as you say. | supersonico | |
10/7/2024 09:16 | Nice to see the Director buying Director/PDMR Shareholding Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technologies for use in the global crop protection, animal health and consumer products industries, announces that on 10 July 2024, Derek McAllan, Non-Executive Director, has purchased 323,017 ordinary shares of £0.01 each in the Company ("Ordinary Shares") at a price of 4.6437 pence per Ordinary Share. Following the purchase outlined above, Derek McAllan's interest in the share capital of the Company is 323,017 Ordinary Shares, representing 0.06 per cent. of the Company's issued share capital. | monet | |
10/7/2024 09:13 | Babysitter, Agreed it's not even relevant as it's so far behind Eden. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions